Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06397755 | Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery. | recruiting | — | 20,000 | IRCCS San RaffaeleOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT06357416 | The Man Van Project(MV) | recruiting | N/A | 4,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06387056 | Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)(SEGNO) | recruiting | Phase 2 | 40 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT04838899 | Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer | recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06350825 | Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients | recruiting | Phase 3 | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT06335693 | Adjuvant Hypofractionated Radiotherapy for Prostate Cancer | recruiting | N/A | 9 | Changhai HospitalOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT06330909 | Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rt(HypoF-SBRT) | recruiting | N/A | 374 | University Hospital FreiburgOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06320223 | PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer(PROMISE-PET) | recruiting | — | 10,000 | University Hospital, EssenOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06321679 | Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone(RESPECT) | recruiting | — | 40 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06318559 | Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention(RIDERS) | recruiting | N/A | 120 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT05116475 | Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases(ALADDIN) | recruiting | Phase 3 | 152 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06305832 | Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | recruiting | Phase 2 | 102 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06292897 | Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression(OBESITA'&PCa) | recruiting | — | 25 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT04612907 | Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer(Hypo-M1) | recruiting | N/A | 420 | Umeå UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04642027 | PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy(PERYTON) | recruiting | Phase 3 | 538 | University Medical Center GroningenOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06270043 | Focal Therapy for Localized Prostate Cancer | recruiting | — | 500 | University of California, San DiegoOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06041555 | MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)(ISRAR) | recruiting | — | 600 | Hospices Civils de LyonOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06223295 | Effectiveness of Focal Therapy in Men With Prostate Cancer(ENFORCE) | recruiting | N/A | 356 | Radboud University Medical CenterOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06259123 | Neoadjuvant PSMA-RLT in Oligometastatic PCa | recruiting | Phase 2 | 10 | Medical University of ViennaOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06249750 | Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer | recruiting | Phase 2 | 60 | Pengyuan LiuOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT06219746 | 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer | recruiting | N/A | 320 | Turku University HospitalOTHER_GOV | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04831983 | ABlative Radiotherapy (for) Unfavorable Prostate Tumors(ABRUPT) | recruiting | — | 30 | University of Milano BicoccaOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT06177015 | Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC | recruiting | Phase 3 | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT03908684 | Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers | recruiting | — | 320 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT04242017 | Long-term Better Than Short-term ADT With Salvage RT(LOBSTER) | recruiting | Phase 2 / Phase 3 | 394 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06167629 | Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer | recruiting | — | 2,500 | IRCCS San RaffaeleOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT05767307 | Danish Prostate Cancer Consortium Study-1(DPCC-1) | recruiting | — | 2,500 | Aarhus University HospitalOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT05781217 | Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624(URONCOR 06-24) | recruiting | Phase 3 | 534 | Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología RadioterápicOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06116019 | Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)(ART-02) | recruiting | — | 649 | Charite University, Berlin, GermanyOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT06116851 | Prostate Metabolism, Cancer Risk and Gut Microbiota(PROMIC) | recruiting | — | 300 | Turku University HospitalOTHER_GOV | 1 | Nov 3, 2023 | clinicaltrials |
| NCT03034187 | Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate(SFP-PROSTATE) | recruiting | — | 10,000 | University Medical Center GroningenOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT05832736 | Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer(RETURN) | recruiting | N/A | 36 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT04549688 | Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer | recruiting | N/A | 250 | The Hospital of VestfoldOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT06001619 | Prostate Medication, Metabolism and Gut Microbiota(PROMED) | recruiting | Phase 4 | 100 | Turku University HospitalOTHER_GOV | 1 | Aug 21, 2023 | clinicaltrials |
| NCT05983783 | Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC | recruiting | Phase 3 | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT04654338 | 2 Ablative RadioTherapy Treatments for Prostate Cancer(EARTH) | recruiting | Phase 2 / Phase 3 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Jun 27, 2023 | clinicaltrials |
| NCT05884632 | Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients(DART-PHASER) | recruiting | N/A | 184 | IRCCS Sacro Cuore Don Calabria di NegrarOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05209243 | START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC(START-MET) | recruiting | N/A | 266 | Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología RadioterápicOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05019846 | SRT Versus SRT+ADT in Prostate Cancer(SPA) | recruiting | Phase 3 | 310 | Marco Lorenzo BonuOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04861415 | SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer(SHARP) | recruiting | N/A | 55 | Dr. Gerard MortonOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05054296 | Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring | recruiting | Phase 2 | 200 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05753566 | Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | recruiting | Phase 2 | 96 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT05672485 | 99mTc-P137 SPECT/CT in Prostate Cancer | recruiting | N/A | 40 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05722392 | Safety and Efficacy of Two-step Radical Prostatectomy | recruiting | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT03836196 | Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease(OPTiMAL) | recruiting | N/A | 105 | British Columbia Cancer AgencyOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT04625556 | Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome | recruiting | — | 3,000 | Yonsei UniversityOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT02381990 | MRI/Ultrasound Fusion Guided Prostate Cryotherapy(FIPC) | recruiting | — | 5,000 | Urological Research Network, LLCOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05241236 | MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer(MRFLA) | recruiting | — | 5,000 | Urological Research Network, LLCOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05698576 | TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer(TPF-LITT) | recruiting | N/A | 20 | Urological Research Network, LLCOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05597852 | Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer(FIRST STAR) | recruiting | N/A | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 28, 2022 | clinicaltrials |
Data updated 23 days agoSource updated May 3, 2024source: clinicaltrials